science-commercialization
(4)
Sonia Sennik and the science of a second chance
Before leading Creative Destruction Lab, Sonia Sennik managed engineering projects and coached Ontario rugby. Across those worlds, a question follows her: how do you help people turn potential into something that works?
Hello Tomorrow makes science worth a meeting
A laboratory breakthrough needs someone willing to buy, fund or build it. Hello Tomorrow has made a business of getting those people into the same room.
Chris Tolles Is Building a Tape Measure for the Dirt
The furniture designer turned climate founder is betting that better soil data can make carbon claims more credible - and regenerative agriculture more useful to the people who actually work the land.
Eric Marcotulli
Eric Marcotulli is the co-founder and CEO of Elysium Health, a New York consumer health company he started in 2014 to turn academic aging research into products people can actually buy. A former wrestler who became Sequoia Capital's youngest partner before he turned 30, he left venture capital after a business-school case study on cellular aging convinced him that longevity was a solvable engineering problem, not a fairy tale. He built Elysium by recruiting Nobel laureates and a roster of world-class scientists as advisors, raising more than $70 million across several rounds, and selling directly to consumers.